{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:15:37Z","timestamp":1792782937305,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Oita University","id":[{"id":"https:\/\/ror.org\/01nyv7k26","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic kidney disease (DKD) can progress even in the absence of overt albuminuria, highlighting the need for markers for evaluating nonglomerular pathways. The extracellular-to-total body water ratio (ECW\/TBW), measured via bioelectrical impedance analysis (BIA), reflects systemic fluid status; however, its longitudinal relevance to DKD progression remains unclear to date.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a retrospective observational cohort study using longitudinal outpatient data from October 2020 to April 2025 at the Diabetic Kidney Disease Prevention Clinic, Oita University Hospital. A total of 40 adults with type 2 diabetes and clinically diagnosed DKD contributed 355 outpatient visits. The primary outcome was the annual rate of decline in estimated glomerular filtration rate (eGFR slope, mL\/min\/1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      \/year).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Both baseline and time-averaged ECW\/TBW values were negatively correlated with eGFR slope in the univariate analysis (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.014 and 0.025, respectively) and remained significant in the multivariate models. Log-transformed urinary albumin-to-creatinine ratio (UACR) was also significantly associated with faster eGFR decline. Treatment with sodium\u2013glucose cotransporter 2 inhibitors (SGLT2is) was associated with lower ECW\/TBW values, whereas other renoprotective medications exerted more modest individual effects, with greater reductions observed with the concurrent use of multiple agents.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Higher ECW\/TBW values were associated with faster eGFR decline in DKD, suggesting that subclinical volume overload may represent a potential nonglomerular mechanism of disease progression. This volume-related burden may be attenuated by SGLT2is therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10157-026-02905-x","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:27:26Z","timestamp":1781843246000},"page":"1457-1467","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between extracellular-to-total body water ratio and eGFR decline in diabetic kidney disease: a longitudinal cohort study"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2538-9839","authenticated-orcid":false,"given":"Shotaro","family":"Miyamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Imaishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machiko","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyoko","family":"Osue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Sada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Ozeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koro","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6506-4820","authenticated-orcid":false,"given":"Hirotaka","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"issue":"10225","key":"2905_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709\u201333.","journal-title":"Lancet"},{"issue":"12","key":"2905_CR2","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032\u201345.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"24","key":"2905_CR3","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1001\/jama.289.24.3273","volume":"289","author":"HJ Kramer","year":"2003","unstructured":"Kramer HJ, Nguyen QD, Curhan G, Hsu CY. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA. 2003;289(24):3273\u20137.","journal-title":"JAMA"},{"issue":"9","key":"2905_CR4","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1097\/HJH.0b013e3283495cd6","volume":"29","author":"G Penno","year":"2011","unstructured":"Penno G, Solini A, Bonora E, Fondelli C, Orsi E, Zerbini G, et al. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens. 2011;29(9):1802\u20139.","journal-title":"J Hypertens"},{"issue":"11","key":"2905_CR5","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s00109-005-0688-7","volume":"83","author":"A Bierhaus","year":"2005","unstructured":"Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl). 2005;83(11):876\u201386.","journal-title":"J Mol Med (Berl)"},{"issue":"suppl_3","key":"2905_CR6","doi-asserted-by":"publisher","first-page":"S233","DOI":"10.1097\/01.ASN.0000077408.15865.06","volume":"14","author":"SS Chung","year":"2003","unstructured":"Chung SS, Ho EC, Lam KS, Chung SK. Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol. 2003;14(suppl_3):S233\u20136.","journal-title":"J Am Soc Nephrol"},{"key":"2905_CR7","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1038\/sj.ki.5002386","volume":"72","author":"H Noh","year":"2007","unstructured":"Noh H, King G. The role of protein kinase C activation in diabetic nephropathy. Kidney Int. 2007;72:S49\u201353.","journal-title":"Kidney Int"},{"issue":"3","key":"2905_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000447434","volume":"133","author":"R Hojs","year":"2016","unstructured":"Hojs R, Ekart R, Bevc S, Hojs N. Markers of inflammation and oxidative stress in the development and progression of renal disease in diabetic patients. Nephron. 2016;133(3):159\u201362.","journal-title":"Nephron"},{"issue":"4","key":"2905_CR9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1681\/ASN.2016060666","volume":"28","author":"L Tonneijck","year":"2017","unstructured":"Tonneijck L, Muskiet MH, Smits MM, van Bommel EJ, Heerspink HJ, van Raalte DH, et al. Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment. J Am Soc Nephrol. 2017;28(4):1023\u201339.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2905_CR10","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.2337\/diabetes.52.4.1031","volume":"52","author":"M Dalla Vestra","year":"2003","unstructured":"Dalla Vestra M, Masiero A, Roiter AM, Saller A, Crepaldi G, Fioretto P. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes. 2003;52(4):1031\u20135.","journal-title":"Diabetes"},{"issue":"5","key":"2905_CR11","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.semnephrol.2012.07.008","volume":"32","author":"JV Bonventre","year":"2012","unstructured":"Bonventre JV. Can we target tubular damage to prevent renal function decline in diabetes? Semin Nephrol. 2012;32(5):452\u201362.","journal-title":"Semin Nephrol"},{"issue":"3","key":"2905_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF00252649","volume":"21","author":"RA DeFronzo","year":"1981","unstructured":"DeFronzo RA. The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia. 1981;21(3):165\u201371.","journal-title":"Diabetologia"},{"issue":"4","key":"2905_CR13","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s00125-023-06068-2","volume":"67","author":"AG Hoek","year":"2024","unstructured":"Hoek AG, Dal Canto E, Wenker E, Bindraban N, Handoko ML, Elders PJM, et al. Epidemiology of heart failure in diabetes: a disease in disguise. Diabetologia. 2024;67(4):574\u2013601.","journal-title":"Diabetologia"},{"issue":"7","key":"2905_CR14","doi-asserted-by":"publisher","first-page":"e294","DOI":"10.1161\/CIR.0000000000000691","volume":"140","author":"SM Dunlay","year":"2019","unstructured":"Dunlay SM, Givertz MM, Aguilar D, Allen LA, Chan M, Desai AS, et al. Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update. Circulation. 2019;140(7):e294\u2013324.","journal-title":"Circulation"},{"issue":"6","key":"2905_CR15","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","volume":"31","author":"C Ronco","year":"2010","unstructured":"Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J. 2010;31(6):703\u201311.","journal-title":"Eur Heart J"},{"issue":"12","key":"2905_CR16","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.cardfail.2012.10.010","volume":"18","author":"EA Ross","year":"2012","unstructured":"Ross EA. Congestive renal failure: the pathophysiology and treatment of renal venous hypertension. J Card Fail. 2012;18(12):930\u20138.","journal-title":"J Card Fail"},{"issue":"7","key":"2905_CR17","doi-asserted-by":"publisher","first-page":"e2248","DOI":"10.1210\/clinem\/dgae768","volume":"110","author":"N Kajitani","year":"2025","unstructured":"Kajitani N, Umakoshi H, Kajitani Y, Kaneko H, Matsuzaki C, Miyachi Y, et al. Relationship between extracellular water to total body water ratio and severe diabetic retinopathy in type 2 diabetes. J Clin Endocrinol Metab. 2025;110(7):e2248\u201355.","journal-title":"J Clin Endocrinol Metab"},{"key":"2905_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12206676","author":"S Hwang","year":"2023","unstructured":"Hwang S, Seong M, Kang MH, Thng ZX, Cho H, Shin YU. Association of a bioimpedance profile with optical coherence tomography features in diabetic macular edema. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12206676.","journal-title":"J Clin Med"},{"key":"2905_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.857532","volume":"9","author":"J Yao","year":"2022","unstructured":"Yao J, Peng Q, Li Y, Liang A, Xie J, Zhuang X, et al. Clinical relevance of body fluid volume status in diabetic patients with macular edema. Front Med (Lausanne). 2022;9:857532.","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"2905_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2021.107930","volume":"35","author":"S Low","year":"2021","unstructured":"Low S, Pek S, Liu YL, Moh A, Ang K, Tang WE, et al. Higher extracellular water to total body water ratio was associated with chronic kidney disease progression in type 2 diabetes. J Diabetes Complications. 2021;35(7):107930.","journal-title":"J Diabetes Complications"},{"key":"2905_CR21","doi-asserted-by":"crossref","unstructured":"KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022;102(5s):S1-s127.","DOI":"10.1016\/j.kint.2022.06.008"},{"issue":"6","key":"2905_CR22","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982\u201392.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2905_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1053\/j.ajkd.2012.07.007","volume":"61","author":"M Horio","year":"2013","unstructured":"Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S. GFR estimation using standardized serum cystatin C in Japan. Am J Kidney Dis. 2013;61(2):197\u2013203.","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"2905_CR24","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3390\/diagnostics14111194","volume":"14","author":"M Asakura-Kinoshita","year":"2024","unstructured":"Asakura-Kinoshita M, Masuda T, Oka K, Ohara K, Miura M, Morinari M, et al. Sodium\u2013glucose cotransporter 2 inhibitor combined with conventional diuretics ameliorate body fluid retention without excessive plasma volume reduction. Diagnostics (Basel). 2024;14(11):1194.","journal-title":"Diagnostics (Basel)"},{"key":"2905_CR25","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/391762","volume":"2011","author":"S Horita","year":"2011","unstructured":"Horita S, Seki G, Yamada H, Suzuki M, Koike K, Fujita T. Insulin resistance, obesity, hypertension, and renal sodium transport. Int J Hypertens. 2011;2011:391762.","journal-title":"Int J Hypertens"},{"issue":"4\u20135","key":"2905_CR26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/10739680701283091","volume":"14","author":"SY Yuan","year":"2007","unstructured":"Yuan SY, Breslin JW, Perrin R, Gaudreault N, Guo M, Kargozaran H, et al. Microvascular permeability in diabetes and insulin resistance. Microcirculation. 2007;14(4\u20135):363\u201373.","journal-title":"Microcirculation"},{"issue":"3","key":"2905_CR27","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.kint.2020.02.041","volume":"98","author":"AC Hesp","year":"2020","unstructured":"Hesp AC, Schaub JA, Prasad PV, Vallon V, Laverman GD, Bjornstad P, et al. The role of renal hypoxia in the pathogenesis of diabetic kidney disease: a promising target for newer renoprotective agents including SGLT2 inhibitors? Kidney Int. 2020;98(3):579\u201389.","journal-title":"Kidney Int"},{"issue":"1","key":"2905_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/sj.ki.5002567","volume":"73","author":"C Rosenberger","year":"2008","unstructured":"Rosenberger C, Khamaisi M, Abassi Z, Shilo V, Weksler-Zangen S, Goldfarb M, et al. Adaptation to hypoxia in the diabetic rat kidney. Kidney Int. 2008;73(1):34\u201342.","journal-title":"Kidney Int"},{"issue":"2","key":"2905_CR29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41440-024-01997-w","volume":"48","author":"N Matsuda","year":"2025","unstructured":"Matsuda N, Yoshida Y, Inobe N, Yoshimura M, Iwamoto M, Nagai S, et al. Antihypertensive effects and changes in extracellular water content by mineralocorticoid receptor antagonists in patients with primary aldosteronism. Hypertens Res. 2025;48(2):553\u201362.","journal-title":"Hypertens Res"},{"issue":"9","key":"2905_CR30","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.2215\/CJN.0000000000000217","volume":"18","author":"DK Farrington","year":"2023","unstructured":"Farrington DK, Surapaneni A, Matsushita K, Seegmiller JC, Coresh J, Grams ME. Discrepancies between cystatin C-based and creatinine-based eGFR. Clin J Am Soc Nephrol. 2023;18(9):1143\u201352.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"2905_CR31","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1053\/j.ajkd.2023.04.002","volume":"82","author":"JJ Carrero","year":"2023","unstructured":"Carrero JJ, Fu EL, Sang Y, Ballew S, Evans M, Elinder CG, et al. Discordances between creatinine- and cystatin C-based estimated GFR and adverse clinical outcomes in routine clinical practice. Am J Kidney Dis. 2023;82(5):534\u201342.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2905_CR32","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1053\/j.ajkd.2025.03.018","volume":"86","author":"IE McCoy","year":"2025","unstructured":"McCoy IE, Yang J, Go AS, Rincon-Choles H, Taliercio J, Rosas SE, et al. Complex etiologies of the discordance between cystatin C- and creatinine-based estimated GFR and its adverse associations: findings from the CRIC study. Am J Kidney Dis. 2025;86(2):192\u2013201.","journal-title":"Am J Kidney Dis"},{"key":"2905_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-026-02853-6","author":"T Suzuki","year":"2026","unstructured":"Suzuki T, Ichikawa K, Suzuki N, Watanabe M, Konta T. Discrepancy between cystatin C-based and creatinine-based eGFR predicts all-cause mortality in a community-based population: the Takahata study. Clin Exp Nephrol. 2026. https:\/\/doi.org\/10.1007\/s10157-026-02853-6.","journal-title":"Clin Exp Nephrol"},{"issue":"5","key":"2905_CR34","doi-asserted-by":"publisher","first-page":"873","DOI":"10.2337\/dc23-2364","volume":"47","author":"D He","year":"2024","unstructured":"He D, Gao B, Wang J, Yang C, Zhao MH, Zhang L. The difference between cystatin C- and creatinine-based estimated glomerular filtration rate and risk of diabetic microvascular complications among adults with diabetes: a population-based cohort study. Diabetes Care. 2024;47(5):873\u201380.","journal-title":"Diabetes Care"},{"issue":"7","key":"2905_CR35","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.2337\/dci25-0029","volume":"48","author":"RJ MacIsaac","year":"2025","unstructured":"MacIsaac RJ. Mind the gap: discordance between cystatin C and creatinine eGFR and diabetes complications. Diabetes Care. 2025;48(7):1158\u201360.","journal-title":"Diabetes Care"},{"key":"2905_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13098-020-00545-z","volume":"12","author":"K Ohara","year":"2020","unstructured":"Ohara K, Masuda T, Morinari M, Okada M, Miki A, Nakagawa S, et al. The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease. Diabetol Metab Syndr. 2020;12:37.","journal-title":"Diabetol Metab Syndr"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02905-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-026-02905-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02905-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:51:17Z","timestamp":1789613477000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-026-02905-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2905"],"URL":"https:\/\/doi.org\/10.1007\/s10157-026-02905-x","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"1 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was received, using an opt-out approach in accordance with the ethical guidelines for medical research involving human subjects in Japan. The study protocol was approved by the Ethics Committee of Oita University Hospital (approval number: 3,187). Information regarding the study was disclosed on the institution\u2019s website to provide patients the opportunity to decline participation.","order":2,"name":"Ethics","label":"Informed patient consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}